Selective inhibition of Periostin variant (PN1) by monoclonal antibody
CHRNB2, a novel target for gastric cancer, potentially other tumors
Predicting therapeutic efficacy of combined immunotherapy such as atezolizumab/bevacizumab using CD1…
Improvement of cilial dysfunction by FGFR inhibitor through ICK/MAK pathway activation.
A novel therapeutic approach for systemic anti-tumor immunity utilizing apolipoproteins
Induces migration of newly generated neurons to the injured area by improving the microenvironment o…
Using vesicles derived from the cell membrane of target bacteria allows for highly species-specific …
Identification of prostaglandin receptors involved in the pathogenesis of endometriosis. [Collaborat…
This system has the capability to recognize human brain activity through the execution of time serie…
Safe molecular design that allows RI to be rapidly excreted into the urine by providing a tubule-spe…